jcm-logo

Journal Browser

Journal Browser

Rehabilitation and Treatment of Post-COVID-19 Condition

A special issue of Journal of Clinical Medicine (ISSN 2077-0383). This special issue belongs to the section "Clinical Rehabilitation".

Deadline for manuscript submissions: 20 January 2026 | Viewed by 9

Special Issue Editor


E-Mail Website
Guest Editor
1. Department of Clinical Sciences, Karolinska Institute, Danderyd University Hospital, 18288 Stockholm, Sweden
2. Multidisciplinary Pain Clinic, Capio St. Göran Hospital, 11219 Stockholm, Sweden
3. Department of Physical and Rehabilitation Medicine, Danderyd University Hospital, 18288 Stockholm, Sweden
Interests: fatigue; chronic pain; disability; myalgic encephalomyelitis/chronic fatigue syndrome; COVID-19
Special Issues, Collections and Topics in MDPI journals

Special Issue Information

Dear Colleagues,

In spring 2025, it will be 5 years since the SARS-CoV-2 pandemic started. It is difficult to forget March 2020, the start of something that was so unfamiliar at that time. The initial research on the acute disease stage was followed by papers on remaining symptoms, later named “post-COVID-19 condition” by WHO.

Many scientific journals published Special Issues on COVID and post-COVID, describing many aspects of the acute pathophysiology, multifaceted clinical picture, and the following symptoms in terms of the post-COVID-19 condition. Now, almost 5 years later, we hope that studies being conducted to treat and rehabilitate patients with the post-COVID-19 condition are still in the pipeline.

Therefore, this Special Issue aims to focus on both pharmacological and non-pharmacological interventions, which are important in the interdisciplinary management of the post-COVID-19 condition. For some patients, the symptoms become more persistent while others have recover. Some of the patients may develop a  condition called “myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS)”. ME/CFS patients suffer from post-exertional malaise and postural orthostatic tachycardia syndrome, both observed in cases of disabling post-COVID-19 condition. We argue that it is important to follow-up and share research worldwide. This will help us to prepare for challenging situations to come, if needed.

In this Special Issue, different types of original articles and reviews on the evolution and management of the post-COVID-19 condition are welcome. Research areas may include (but are not limited to) the following: long-lasting remaining symptoms and disability as a result of the post-COVID-19 condition; treatment and rehabilitation approaches, including digital ones; the impact on the quality of life; health literacy regarding the post-COVID-19 condition; and return to work.

Dr. Indre Bileviciute-Ljungar
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Clinical Medicine is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • post-COVID-19 condition
  • myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS)
  • comorbidities
  • interdisciplinary
  • multimodal
  • digital medicine
  • rehabilitation
  • treatment
  • health-related quality of life
  • disability
  • return to work

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.

Further information on MDPI's Special Issue policies can be found here.

Published Papers

This special issue is now open for submission.
Back to TopTop